The prevalence of hepatopulmonary syndrome in 445 patients, candidates to hepatic transplant Source: Eur Respir J 2004; 24: Suppl. 48, 562s Year: 2004
Incidence of primary graft dysfunction (PGD) with radiological abnormalities in 249 consecutive single lung transplant patients Source: Eur Respir J 2005; 26: Suppl. 49, 176s Year: 2005
Characteristics of the hepatopulmonary syndrome in cirrhotic patients, pre and postransplantation Source: Eur Respir J 2006; 28: Suppl. 50, 546s Year: 2006
Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020
Effect of the type of end-stage lung disease on postoperative evolution of lung transplantation patients Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012
Sixteen years‘ experience of lymphoproliferative disease following lung transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 174s Year: 2007
Pulmoanry hypertension is a negative prognostic factot of long term survival in patients with idiopathic pulmonary fibrosis after lung transplantation Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Pulmonary evaluation findings of liver transplant candidates: analysis of 341 adult patients Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007
Assessment of the restrictive allograft syndrome in patients after lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012
Diagnosis of antibody-mediated rejection (AMR) on lung transplant biopsies: A retrospective single-center case study Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018
Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experience Source: Eur Respir J, 53 (2) 1801096; 10.1183/13993003.01096-2018 Year: 2019
Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019 Year: 2020
Orthodeoxia in patients listed for liver transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 346s Year: 2007
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011
Patients on lung transplantation waiting list: characteristics and aetiology Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009
Results of sleep study conducted for one week in patients with end-stage renal disease undergoing maintenance hemodialysis. Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019
The prevalence of pulmonary hypertension in cirrhotic patients submitted to hepatic transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 465s Year: 2003
Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008